Notably, CTO and RVD (defined as a diameter of less than 5 mm) emerged as an anatomical factor contributing to loss of primary patency at the 2-year mark; however, this association did not reach statistical significance at the 3-year follow-up.
← all excerpts
Three-year outcomes of the TCD-17187 (Kanshas) drug-coated balloon for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery.
1
—
—